BFCFSI
COGT icon

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.’s Cogent Biosciences COGT Stock Holding History

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-92
Closed -$3.56K – 1690
2026
Q2 		$3.56K Hold
92
– – ﹤0.01% 1895
2026
Q1 		$3.54K Buy
+92
New +$3.4K ﹤0.01% 1949

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.'s COGT Position: Q3 2026 in Review

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. sold out of Cogent Biosciences (COGT) in Q3 2026, closing a stake of 92 shares — an estimated $3.56K sold.

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. first reported a position in COGT in Q1 2026 and held it in 2 quarters. The position peaked at $3.56K in Q2 2026. 202 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. reported no remaining Cogent Biosciences position as of Q3 2026 after selling out during the quarter.
  • BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. sold 92 Cogent Biosciences shares in Q3 2026, an estimated $3.56K.
  • BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. first reported a position in Cogent Biosciences in Q1 2026 and held it in 2 quarters.
  • BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.'s Cogent Biosciences position peaked at $3.56K in Q2 2026.
  • 202 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.'s 13F filing for Q3 2026, filed 13 Nov 2026.